by ahoffman | Dec 4, 2025 | Featured, Press Release
FOR IMMEDIATE RELEASE SYKESVILLE, MD & BOSTON, MA – NeuImmune Inc. (“NeuImmune”), a biotechnology company pioneering precision glycoengineered biologics for orphan disease and enhanced immunologic delivery for specific disease conditions today announced a strategic...
